ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250).

Matthew Ingham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.